Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results Biotech Investing
Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase Biotech Investing
Bio-Path Announces Interim Data from Phase 2 Clinical Trial of Prexigebersen in Combination with Low Dose Cytarabine Biotech Investing
BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal Biotech Investing
Milestone Scientific Reports 46.9% Increase in Sales for the Fourth Quarter of 2017 Biotech Investing
Cerecor Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017 Pharmaceutical Investing
CTD Conducts Initial Review of Safety Data for its Phase I and Phase I/II Trials of Trappsol Cyclo Biotech Investing
Mustang Bio Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights Biotech Investing
Ovid Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Progress Biotech Investing
